Genzyme Corp. CEO Henri Termeer

Genzyme Corp. CEO Henri Termeer

Pankaj Nangia/Bloomberg

Genzyme Corp. chief executive officer Henri Termeer, seen here, says he will fight the Sanofi's $69-a-share offer, saying it undervalues Genzyme’s research pipeline.